Skip to main content
logo
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
10.41
-0.65 (-5.88%)
At close: Mar 11, 2026, 4:00 PM EDT
10.27
-0.14 (-1.34%)
After-hours: Mar 11, 2026, 5:10 PM EDT

Zevra Therapeutics Revenue

In the year 2025, Zevra Therapeutics had annual revenue of $106.47M with 350.91% growth. Zevra Therapeutics had revenue of $34.13M in the quarter ending December 31, 2025, with 183.36% growth.

Revenue (ttm)
$106.47M
Revenue Growth
+350.91%
P/S Ratio
5.62
Revenue / Employee
$1,804,576
Employees
59
Market Cap
611.19M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025106.47M82.86M350.91%
Dec 31, 202423.61M-3.85M-14.02%
Dec 31, 202327.46M17.00M162.58%
Dec 31, 202210.46M-18.19M-63.50%
Dec 31, 202128.65M15.36M115.61%
Dec 31, 202013.29M449.00K3.50%
Dec 31, 201912.84M--
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CorMedix311.71M
Rigel Pharmaceuticals294.28M
Vanda Pharmaceuticals216.11M
Century Therapeutics113.34M
Fulcrum Therapeutics80.00M
ADC Therapeutics75.21M
Prothena Corporation9.68M
Altimmune41.00K
Revenue Rankings

ZVRA News

More News